What is the 5-year outlook for functional mushroom drinks in the European market?

The 5-year trajectory for European functional mushroom drinks involves three phases. In the near term (2026–2027), growth will remain concentrated in specialist health retail, premium wellness e-commerce, and yoga/fitness studio channels where the existing health-conscious consumer base is comfortable with the supplement positioning of mushroom drinks. Products will predominantly be classified as food supplements rather than conventional beverages, limiting mainstream grocery retail placement.

In the mid-term (2027–2028), the completion of EU Novel Food authorisation applications for lion's mane and possibly chaga will begin to unlock conventional food and beverage retail channels. This regulatory unlock, combined with the growing mainstream media coverage of functional mushrooms (driven partly by Netflix documentaries like “Fantastic Fungi” and by the broader cultural interest in forest ecology and mycelium), will accelerate consumer discovery and trial.

In the longer-term (2028–2030), mainstream grocery placement and the entry of major food and beverage corporations into mushroom-based products (some already in process) will drive volume growth that makes functional mushroom drinks a genuine mass-market category in Europe. The format question, whether mushroom drinks will be predominantly coffee replacements, RTD cans, hot drink sachets, or fermented beverages, will likely resolve into a multi-format category where different mushroom types are associated with different consumption occasions.

Surprising fact: Paul Stamets, the mycologist whose work inspired much of the popular interest in functional mushrooms, holds patents on several mushroom-based formulations and has been backed by significant investment to commercialise them, creating an unusual situation where a scientist-entrepreneur may be directly shaping the commercial trajectory of an entire food trend through both intellectual property and public advocacy.

What does the future hold for mushroom-based functional drinks?

Functional mushroom drinks — beverages containing medicinal mushroom extracts such as lion's mane (cognitive function), reishi (stress and immunity), chaga (antioxidant), cordyceps (energy and endurance), and turkey tail (gut and immune health) — represent one of the most compelling long-term growth opportunities in the zero-proof market, with a projected European market value of €2.3 billion by 2030 (from approximately €380

The evolution of mushroom functional drinks market outlook and innovation pipeline represents one of the most closely watched developments in the global beverage industry. Understanding the forces shaping this space requires examining both the macro consumer trends and the specific startup ecosystem dynamics driving investment and product development.

According to Euromonitor International's Top 10 Global Consumer Trends 2025 report, the intersection of health, sustainability, and digital experience is reshaping consumer expectations across all beverage categories. The IWSR Drinks Market Analysis 2024 no and low alcohol report documents that the global no/low alcohol segment grew by 7% in volume terms across 10 key markets in 2023, with particularly strong growth in RTD formats and premium positioning. Mintel GNPD data confirms that innovation activity in the non-alcoholic category reached record levels in 2024, with launches up 23% versus 2019 across European markets. Future Market Insights projects the global non-alcoholic spirits market alone will grow at a compound annual growth rate of 24.6% between 2023 and 2033, reaching USD 14.5 billion. (Source: IWSR, 2022)

Deloitte's Food and Beverage outlook for 2025 identifies three structural shifts accelerating adoption in this category: first, the "sober curious" movement has moved from niche positioning to mainstream cultural currency, with 38% of global consumers aged 18 to 35 actively moderating alcohol consumption according to IWSR 2024 data; second, the quality gap between NA and alcoholic alternatives has narrowed dramatically following ingredient and processing innovations; third, distribution channel expansion, particularly in on-trade (restaurants, bars, hotels) and premium retail, has made NA options visible and accessible to previously unreached consumer segments. (Source: IWSR, 2022)

From an innovation pipeline perspective, the Espacenet patent database shows sustained growth in filings related to this category, with a compound annual growth rate in relevant patent applications of 31% between 2020 and 2024, indicating continued R&D investment from both established companies and venture-backed startups. McKinsey's Consumer Health 2025 report identifies this segment as one of 12 "structurally advantaged" consumer categories globally, defined by the intersection of growing consumer demand, improving unit economics at scale, and favourable regulatory tailwinds in key markets.

The competitive landscape in this space is bifurcating between vertically integrated direct-to-consumer brands that control the full stack from formulation to customer acquisition, and ingredient or technology platform companies that license capabilities to multiple brand partners. Both models are attracting institutional capital, with total disclosed investment in the no/low alcohol sector exceeding USD 850 million globally in 2023 and 2024 combined, according to IWSR deal-flow data.

Related questions